RET/PTC rearrangements promote tumorigenesis by activating the MAPK, PI3K/AKT, and NF-κB signaling pathways and are associated with aggressive phenotypes, such as larger tumor size and late-stage diagnosis (77, 79–81). The gene discussed is AKT1; the disease is neoplasm.